RELATING TO INSURANCE.
Summary
Beginning 1/1/2026, requires health insurers, mutual benefit societies, health maintenance organizations, and health plans under the State's Medicaid managed care program to provide coverage for biomarker testing. Effective 7/1/3000. (HD1)
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 17, 2025
Last action Dec 8, 2025
Maddy AI version diff · 1 comparison
What changed between versions
HB553
→
HB553_HD1
·
4 edits
MODERATE
The bill was amended to update administrative metadata, standardize formatting, and correct minor grammatical errors in the definitions of biomarkers and clinical guidelines. The most significant substantive change is the revision of the effective date for Section 8, which was altered from immediate approval to a specific future date of July 1, 3000, likely indicating a placeholder for a future legislative session.
Scope change
The scope of coverage and eligibility criteria for biomarker testing remains unchanged; the amendments focus on text cleanup and a major timeline adjustment.
TIMELINE
The effective date for the bill's implementation was changed from 'upon approval' to 'July 1, 3000', which appears to be a placeholder or error requiring legislative correction.
TECHNICAL
Administrative metadata, including bill numbers, clerk names, and revision dates, were updated to reflect the House of Representatives version (HD1).
A typo in the definition of biomarkers was corrected, changing 'mediations' to 'medications'.
DEFINITION
Minor grammatical improvements were made to the definitions of 'Clinical practice guidelines' and 'Consensus statements' to improve clarity and flow.
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
11
Key actions
2
Committee
4
Feb 6, 2025
Committee
Reported from HLT/HSH (Stand. Com. Rep. No. 185) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
lower
Jan 31, 2025
Lower · Passed
The committee on HSH recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Marten, Olds, Amato, Chun, Keohokapu-Lee Loy, Takayama, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
lower
Jan 31, 2025
Lower · Passed
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
lower
Jan 21, 2025
Committee
Referred to HLT/HSH, CPC, FIN, referral sheet 2
lower
Jan 21, 2025
Introduced
Introduced and Pass First Reading.
lower
Jan 17, 2025
Introduced
Pending introduction.
lower
15 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Amy Perruso
DDemocratic
P
Cory Chun
DDemocratic
P
Gregg Takayama
DDemocratic
P
Ikaika Hussey
DDemocratic
P
Ikaika Olds
DDemocratic
P
Jackson Sayama
DDemocratic
P
Jenna Takenouchi
DDemocratic
P
Kim Coco Iwamoto
DDemocratic
P
Lisa Marten
DDemocratic
P
Mahina Poepoe
DDemocratic
P
Nicole Lowen
DDemocratic
P
Rachele Lamosao
DDemocratic
P
Terez Amato
DDemocratic
P
Tina Grandinetti
DDemocratic
P
Tyson Miyake
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 553
Scope: HI
Hi! I can help you understand HB 553. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline